{"id":"W2897241170","doi":"10.1182/blood-2018-06-858852","title":"Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; Vancouver General Hospital; CancerCare Manitoba; Royal Victoria Hospital; Dalhousie University","funders":"Karyopharm Therapeutics","keywords":"Bortezomib; Dexamethasone; Multiple myeloma; Carfilzomib; Medicine; Refractory (planetary science); Oncology; Internal medicine; Pomalidomide; Lenalidomide; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001452201,0.0002385237,0.0003753876,0.0001188739,0.000170397,0.00002775038,0.00008489291,0.0001174778,0.00008937548],"category_scores_gemma":[0.0009292944,0.000149897,0.00005590643,0.0001709095,0.0001880471,0.0001151914,0.00005365254,0.000142599,0.00004163263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006042403,"about_ca_system_score_gemma":0.0002448494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006303009,"about_ca_topic_score_gemma":0.0001576548,"domain_scores_codex":[0.9983959,0.00004237957,0.0002466176,0.0004611105,0.0003680945,0.0004858678],"domain_scores_gemma":[0.9983037,0.0003586592,0.00009542257,0.0004267102,0.0004054657,0.0004100839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03816033,0.007477598,0.8909952,0.0004725655,0.001337833,0.0002808155,0.000656144,2.275168e-7,0.003792393,0.0000105103,0.001446119,0.05537026],"study_design_scores_gemma":[0.1348533,0.01359183,0.835611,0.000299591,0.0005089711,0.00005532403,0.0000972905,0.0007773321,0.0085,0.00001371801,0.005351833,0.0003396925],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972141,0.0001656689,0.0001420361,0.0001028044,0.00006626252,0.001873699,0.0001221226,0.00008214138,0.0002311181],"genre_scores_gemma":[0.980551,0.00004321301,0.01727182,0.0001453189,0.0002753354,0.0002033474,0.0001903417,0.000060284,0.001259358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09669301,"threshold_uncertainty_score":0.6112623,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02251411635390486,"score_gpt":0.2883741098069045,"score_spread":0.2658599934529997,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}